130 related articles for article (PubMed ID: 20934245)
1. Celastrol inhibits the growth of estrogen positive human breast cancer cells through modulation of estrogen receptor α.
Jang SY; Jang SW; Ko J
Cancer Lett; 2011 Jan; 300(1):57-65. PubMed ID: 20934245
[TBL] [Abstract][Full Text] [Related]
2. Hispolon inhibits the growth of estrogen receptor positive human breast cancer cells through modulation of estrogen receptor alpha.
Jang EH; Jang SY; Cho IH; Hong D; Jung B; Park MJ; Kim JH
Biochem Biophys Res Commun; 2015 Aug; 463(4):917-22. PubMed ID: 26056942
[TBL] [Abstract][Full Text] [Related]
3. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
4. Phloretin Inhibits the Proliferation of Breast Cancer Cells Through the Down-regulation of Estrogen Receptor α.
Jang SY; Kim J; Hong E; Yang YJ; Na Y; Yeom CH; Park S
Anticancer Res; 2024 Mar; 44(3):1109-1120. PubMed ID: 38423666
[TBL] [Abstract][Full Text] [Related]
5. Celastrol induces the apoptosis of breast cancer cells and inhibits their invasion via downregulation of MMP-9.
Mi C; Shi H; Ma J; Han LZ; Lee JJ; Jin X
Oncol Rep; 2014 Dec; 32(6):2527-32. PubMed ID: 25310109
[TBL] [Abstract][Full Text] [Related]
6. A protein-fragment complementation assay reveals that celastrol and gambogic acid suppress ERα mutants in breast cancer.
Liu X; Hu Q; Wang W; Ma H; Pu J; Cui J; Gong T; Wu Y; Lu W; Huang J
Biochem Pharmacol; 2021 Jun; 188():114583. PubMed ID: 33915156
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol synthesis inhibitor RO 48-8071 suppresses transcriptional activity of human estrogen and androgen receptor.
Mafuvadze B; Liang Y; Hyder SM
Oncol Rep; 2014 Oct; 32(4):1727-33. PubMed ID: 25051231
[TBL] [Abstract][Full Text] [Related]
8. Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy.
Bieche I; Parfait B; Le Doussal V; Olivi M; Rio MC; Lidereau R; Vidaud M
Cancer Res; 2001 Feb; 61(4):1652-8. PubMed ID: 11245479
[TBL] [Abstract][Full Text] [Related]
9. Celastrol inhibits breast cancer cell invasion via suppression of NF-ĸB-mediated matrix metalloproteinase-9 expression.
Kim Y; Kang H; Jang SW; Ko J
Cell Physiol Biochem; 2011; 28(2):175-84. PubMed ID: 21865725
[TBL] [Abstract][Full Text] [Related]
10. The natural anti-tumor compound Celastrol targets a Myb-C/EBPβ-p300 transcriptional module implicated in myeloid gene expression.
Coulibaly A; Haas A; Steinmann S; Jakobs A; Schmidt TJ; Klempnauer KH
PLoS One; 2018; 13(2):e0190934. PubMed ID: 29394256
[TBL] [Abstract][Full Text] [Related]
11. Effects of celastrol on human cervical cancer cells as revealed by ion-trap gas chromatography-mass spectrometry based metabolic profiling.
Hu Y; Qi Y; Liu H; Fan G; Chai Y
Biochim Biophys Acta; 2013 Mar; 1830(3):2779-89. PubMed ID: 23142250
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
Al-Dhaheri MH; Rowan BG
Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199
[TBL] [Abstract][Full Text] [Related]
13. Celastrol induces apoptosis in non-small-cell lung cancer A549 cells through activation of mitochondria- and Fas/FasL-mediated pathways.
Mou H; Zheng Y; Zhao P; Bao H; Fang W; Xu N
Toxicol In Vitro; 2011 Aug; 25(5):1027-32. PubMed ID: 21466843
[TBL] [Abstract][Full Text] [Related]
14. Genistin attenuates cellular growth and promotes apoptotic cell death breast cancer cells through modulation of ERalpha signaling pathway.
Hwang ST; Yang MH; Baek SH; Um JY; Ahn KS
Life Sci; 2020 Dec; 263():118594. PubMed ID: 33075375
[TBL] [Abstract][Full Text] [Related]
15. [Inhibitory effect of carbamazepine on proliferation of estrogen-dependent breast cancer cells].
Meng QW; Zhao CH; Xi YH; Cai L; Sun LC; Sui GJ
Ai Zheng; 2006 Aug; 25(8):967-73. PubMed ID: 16965676
[TBL] [Abstract][Full Text] [Related]
16. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M
BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907
[TBL] [Abstract][Full Text] [Related]
17. Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation.
Sethi G; Ahn KS; Pandey MK; Aggarwal BB
Blood; 2007 Apr; 109(7):2727-35. PubMed ID: 17110449
[TBL] [Abstract][Full Text] [Related]
18. Anabolic effect of the traditional Chinese medicine compound tanshinone IIA on myotube hypertrophy is mediated by estrogen receptor.
Zhao P; Soukup ST; Hegevoss J; Ngueu S; Kulling SE; Diel P
Planta Med; 2015 May; 81(7):578-85. PubMed ID: 26018796
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters.
Giulianelli S; Vaqué JP; Soldati R; Wargon V; Vanzulli SI; Martins R; Zeitlin E; Molinolo AA; Helguero LA; Lamb CA; Gutkind JS; Lanari C
Cancer Res; 2012 May; 72(9):2416-27. PubMed ID: 22396492
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines.
Alao JP; Lam EW; Ali S; Buluwela L; Bordogna W; Lockey P; Varshochi R; Stavropoulou AV; Coombes RC; Vigushin DM
Clin Cancer Res; 2004 Dec; 10(23):8094-104. PubMed ID: 15585645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]